| | The World Health Organization's head on Tuesday welcomed the United States' move to join a WHO-backed programme to accelerate tools to fight COVID-19, as U.S. President Joseph Biden reverses the Trump Administration's course. | |
| More than 97% of COVID-19 deaths in Israel over the past month were people who had not been vaccinated, Prime Minister Benjamin Netanyahu said on Tuesday, as his government tries to increase turnout for the Pfizer Inc shots. | |
| Christoph Hueck illustrates the challenge Germany faces in rolling out a mass vaccination campaign to tackle the coronavirus pandemic. A scientist living in a wealthy, high-tech region, he does not plan to have any of the shots on offer. | |
| Jose Luis Espinoza had been chasing a COVID-19 vaccine for more than three weeks. | |
| Ukraine's plan to roll out a Chinese-made coronavirus vaccine from next month faces possible delay because of regulatory hold-ups, according to a letter written by the importer, in a further risk to the country's slow-moving vaccination programme. | |
| Ethiopia has secured nine million doses of COVID-19 vaccines up until April and hopes to inoculate at least a fifth of its 110 million people by the end of the year, the health minister said on Tuesday. | |
| Hungary will start vaccinating people suffering no chronic diseases with Russia's Sputnik COVID-19 vaccine soon, the surgeon general said on Tuesday, becoming the first European Union country to use it. | |
| The head of the World Health Organization-led team in the central Chinese city of Wuhan probing the origins of COVID-19 said on Tuesday that cold chain transmission of the virus is a possibility and warrants further investigation. | |
| The head of the World Health Organization-led team of experts investigating the origins of COVID-19, Peter Ben Embarek, said on Tuesday that it was "very unlikely" that a leak from a laboratory was the source of the outbreak. | |
| Johnson & Johnson is interested in manufacturing its COVID-19 vaccine in India, a government official told a news conference on Tuesday. | |
| Dermapharm aims to start making the COVID-19 vaccine from BioNTech and U.S. partner Pfizer at a second site in Germany in May, its chief executive said, as part of efforts to ramp up production to meet demand. | |
|
| |